Skizoril
Skizoril (Clozapine 25/50/100 mg) — gold-standard atypical for treatment-resistant schizophrenia. only antipsychotic with proven anti-suicide effect — needs FBC monitoring.
✓ Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience · Last reviewed: May 2026
⚡ Quick Answer
Skizoril (Clozapine 25 / 50 / 100 mg) is the most effective antipsychotic for treatment-resistant schizophrenia, but with the heaviest monitoring burden in modern psychiatry. Mandatory weekly FBC for the first 18 weeks because of agranulocytosis risk. Specialist initiation only.
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
Why order from MedsBase
Skizoril at MedsBase is supplied directly from a WHO-GMP certified manufacturer in plain, discreet packaging. Every order is covered by our Reshipment Assurance Policy — 20-business-day arrival window or we reship at no charge — and qualifies for our customer loyalty programme. Worldwide shipping is available to most destinations.
What Skizoril is and how it works
Skizoril is a clozapine tablet supplied by Sun Pharma. Available strengths: 25 / 50 / 100 mg. Clozapine is the most effective antipsychotic ever developed for treatment-resistant schizophrenia (CATIE Phase 2, 2006; CUtLASS 1, 2006). It is also the only antipsychotic with reproducible evidence for reducing suicide rate in schizophrenia (InterSePT, 2003). The mechanism is broad: weak D2 antagonism (low EPS, low TD), strong 5-HT2A and D4 antagonism, strong α1 and H1 blockade, and strong M1/M3 antagonism. Despite its efficacy, clozapine is reserved for treatment-resistant disease because of the severe monitoring burden.
Indications and dosing
| Indication | Starting | Target | Max |
|---|---|---|---|
| Treatment-resistant schizophrenia | 12.5 mg HS day 1, then 25 mg BID, then up by 25–50 mg/day | 300–450 mg/day in divided doses | 900 mg |
| Schizophrenia with suicidality | same as above | same | same |
| Treatment-resistant bipolar (off-label) | 12.5 mg HS | 200–500 mg/day | by tolerability |
| Older adults | 12.5 mg OD | 50–200 mg/day | by tolerability |
Slow titration is mandatory — fast titration produces severe orthostasis and seizures. The “dose drop” rule: if a patient misses ≥ 2 days of clozapine, restart from low dose and re-titrate.
Important safety considerations
Clozapine causes a clinically significant neutropenia in approximately 3% of patients and severe agranulocytosis (ANC < 500) in approximately 0.8%. Risk is highest in the first 18 weeks but never zero. Mandatory FBC schedule: baseline → weekly × 18 weeks → 2-weekly × weeks 19–52 → monthly thereafter. Stop immediately if ANC drops below cut-offs (varies by registry: usually < 1500 amber, < 1000 red). Most countries require a national clozapine registry that the prescriber and dispensing pharmacy must check before each supply.
Clozapine causes myocarditis (especially in the first 4 weeks) and dilated cardiomyopathy (months to years later). Baseline ECG, troponin, CRP, and echocardiogram are increasingly recommended. Stop immediately for unexplained chest pain, dyspnoea, fever, palpitations, or unexplained tachycardia in the first 6–8 weeks.
~1% at 300 mg/day; ~5% at 600+ mg/day. Anticonvulsant cover (often valproate) is added for high-dose clozapine. Avoid drugs that lower seizure threshold (bupropion, tramadol).
The strong M1/M3 anticholinergic effect produces severe constipation and rare cases of ileus, megacolon, and bowel necrosis (clozapine-induced gastrointestinal hypomotility, CIGH). Mortality from CIGH may exceed agranulocytosis mortality. Active bowel-motility management from initiation.
Clozapine produces the heaviest weight gain and metabolic syndrome of any antipsychotic — alongside olanzapine. Mandatory monitoring of weight, fasting glucose, fasting lipids.
Most patients drool, particularly at night. Counterintuitive (anticholinergic effect should reduce salivation; clozapine paradoxically stimulates salivary M4 receptors). Manageable with topical atropine drops or clonidine.
Common side effects
- Sedation — universal, profound at initiation.
- Hypersalivation — universal at night.
- Tachycardia — universal.
- Constipation — universal; manage actively.
- Weight gain and metabolic syndrome — heavy.
- Orthostatic hypotension — common at initiation.
- Nocturnal enuresis — common.
- Fever in first 1–4 weeks — usually benign but indistinguishable initially from agranulocytosis or NMS — always check FBC and clinical picture.
Drug interactions
- Strong CYP1A2 inhibitors (fluvoxamine, ciprofloxacin) — raise clozapine levels several-fold; halve dose.
- Smoking — induces CYP1A2; smokers have lower levels and need higher doses; abrupt cessation can cause toxicity.
- Carbamazepine — induces CYP3A4 + bone-marrow concern; usually avoided in combination.
- Other CNS depressants — additive sedation and respiratory depression.
- Other myelosuppressive drugs (chemotherapy, mirtazapine, anticonvulsants) — additive bone-marrow risk.
Pregnancy, breastfeeding, paediatric
Pregnancy: limited data; usually continued through pregnancy if benefit established. Breastfeeding: passes into milk and can produce neonatal neutropenia; requires monitoring. Paediatric: not first-line; specialist use only.
Storage
Store at 15–30 °C in original packaging.
Frequently Asked Questions
Why is clozapine reserved for treatment-resistant disease?
Clozapine is the most effective antipsychotic, but the monitoring burden (weekly FBC for 18 weeks, then 2-weekly, then monthly for life) and the side-effect profile (heavy weight gain, severe constipation, drooling, sedation) mean the risk-benefit only favours its use after at least two adequate trials of other antipsychotics have failed. About 30% of schizophrenia is treatment-resistant; clozapine is the gold-standard option for that group.
What happens if I miss doses?
Missing 2 or more days requires restarting the titration from a low dose. The strong α1 blockade means a sudden full dose after even a brief gap can produce severe hypotension, syncope, or seizure. Always tell the prescriber if doses have been missed — never just take a make-up dose at the previous strength.
Why do I need a blood test every week?
Clozapine causes a small but real risk of severe agranulocytosis (the bone marrow stops making neutrophils). Without monitoring, agranulocytosis is a leading cause of death in clozapine-treated patients. With weekly FBC for the first 18 weeks, then graduated frequency, the risk is detectable and manageable — patients are stopped at the first amber signal.
Why is constipation taken so seriously on clozapine?
Clozapine’s anticholinergic effect on the gut can produce severe constipation, ileus, megacolon, and rare bowel necrosis. Mortality from clozapine-induced gastrointestinal hypomotility (CIGH) is substantial. Active bowel management from week 1 — high-fibre diet, fluids, regular laxatives — and prompt review of any abdominal symptom is mandatory.
Why am I drooling on clozapine?
Counterintuitive — clozapine’s anticholinergic effect should reduce salivation, but it paradoxically stimulates salivary M4 receptors, producing sialorrhoea (drooling), especially at night. Topical sublingual atropine drops, glycopyrrolate, or clonidine reduce this effectively.
How long until clozapine works?
Some patients respond within 4–6 weeks; the full benefit can take 3–6 months. Patients who have failed multiple other antipsychotics often respond meaningfully to clozapine — it is worth the slow titration and monitoring burden in that group.
Why do smokers need higher doses?
Tobacco smoke is a potent CYP1A2 inducer, and clozapine is largely metabolised by CYP1A2. Smokers therefore reach lower plasma levels at any given dose. Abrupt smoking cessation (e.g. hospital admission) can produce clozapine toxicity within days as plasma levels rise.
Can clozapine be stopped abruptly?
No — taper over weeks to months. Abrupt cessation produces severe cholinergic rebound (severe nausea, GI upset, sweating) and a high relapse risk. Patients with treatment-resistant schizophrenia who relapse on stopping clozapine often have a worse course than they had before clozapine.
Will clozapine make me gain weight?
Yes — among the heaviest, alongside olanzapine. Typical 6-kg gain in 6 months, sometimes much more. Active weight-management from week 1 is essential.
Why does clozapine reduce suicide rate?
Clozapine is the only antipsychotic with reproducible evidence for reducing suicide in schizophrenia (InterSePT, 2003). The mechanism is unclear; it may be a combination of better symptom control, mood-stabilising effect, and direct anti-suicidality. The effect size is meaningful — roughly halving the suicide rate.
Other Mental Health Medications
- Aripicon (Aripiprazole — D2 partial agonist)
- Olanzap (Olanzapine — robust antipsychotic)
- Risdone (Risperidone)
- Seroquit (Quetiapine — bipolar depression)
- Atlura (Lurasidone — metabolically clean)
More options in Mental Health and Psychiatric Medications
Ranked by recent MedsBase order volume — what other customers in this category are picking.
| Strength | 25 mg, 50 mg, 100 mg |
|---|---|
| Quantity | 30 Tablet/s, 60 Tablet/s, 90 Tablet/s, 180 Tablet/s |
Skizoril
Ερωτήσεις & Απαντήσεις
Skizoril
Σχετικά προϊόντα
Κριτικές
Δεν υπάρχουν ακόμη κριτικές